Physician profile
Barbara Cingel
NPI 1386603389
$980.41
in general payments reported to CMS, 2019-2025
17 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $461 · 2023: $273 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $221.95 | 2022-2023 | Andexxa |
| Lilly USA, LLC | $182.84 | 2022-2025 | Zepbound, Trulicity, Mounjaro |
| Glaxosmithkline, LLC. | $125.01 | 2025 | Benlysta |
| Xeris Pharmaceuticals, INC. | $89.28 | 2023 | Gvoke Hypopen |
| Dexcom, INC. | $71.95 | 2022-2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $46.46 | 2022-2023 | Freestyle Libre 2 |
| Novo Nordisk INC | $44.62 | 2022-2023 | Ozempic, Rybelsus |
| Neurocrine Biosciences, INC. | $30.05 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.15 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.74 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.99 | 2022 | |
| Amgen INC. | $17.95 | 2023 | Repatha |
| Exact Sciences Corporation | $17.75 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $14.79 | 2023 | Ubrelvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $14.34 | 2022 | |
| Esperion Therapeutics, INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Cingel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.